Clinical trials
Terminated Phase 2 Lymphoma, T-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2017 | 3 |
| 2019 | 2 |
| 2020 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| miRagen Therapeutics, Inc. | 2 |
| Alaunos Therapeutics | 1 |
| Brown University | 1 |
| Celgene | 1 |
| Dana-Farber Cancer Institute | 1 |
| Emergent BioSolutions | 1 |
| Fondazione Italiana Linfomi - ETS | 1 |
| Fred Hutchinson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell | 18 |
| Lymphoma | 8 |
| Lymphoma, Non-Hodgkin | 8 |
| Lymphoma, Large-Cell, Anaplastic | 4 |
| Immune System Diseases | 3 |
| Immunoproliferative Disorders | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Leukemia, Myeloid, Acute | 3 |
| Lymphatic Diseases | 3 |
| Lymphoma, B-Cell | 3 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.